Editor's note: Alicia Machado told the Guardian in 2016 that she'd become a citizen just in time not to vote for Trump.

If you are what you wear, then Donald Trump’s aesthetic is sending out a confused message. His suits are mostly boxy and ...

A radical plan by a former Trump aide seeks to encourage obese Americans to lose weight—by helping their wallet. Robert P.

Court rulings against parts of Donald Trump's agenda put White House officials on the defensive. Hamas says it will not ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

This is the incredible story of a young Naga Sadhu who realized his spiritual calling at just 10 years old. Leaving behind worldly attachments, he sought blessings from saints, walked the path of ...

The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion.

but now that will be up to President Donald Trump's new administration. Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...